XML 17 R4.htm IDEA: XBRL DOCUMENT v3.23.1
STATEMENTS OF INCOME - USD ($)
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Revenue    
Product sales $ 37,196,717 $ 25,867,649
Contract research and development 1,056,875 1,119,321
Total revenue 38,253,592 26,986,970
Cost of sales 8,062,311 6,263,090
Gross profit 30,191,281 20,723,880
Expenses    
Research and development 2,583,994 2,925,874
Selling, general, and administrative 1,963,105 1,469,321
Total expenses 4,547,099 4,395,195
Income from operations 25,644,182 16,328,685
Interest income 1,448,655 1,171,128
Income before taxes 27,092,837 17,499,813
Provision for income taxes 4,398,379 2,992,312
Net income $ 22,694,458 $ 14,507,501
Net income per share - basic $ 4.70 $ 3.00
Net income per share - diluted 4.70 3.00
Cash dividends declared per common share $ 4.00 $ 4.00
Weighted average shares outstanding    
Weighted Average Number of Shares Outstanding, Basic 4,830,826 4,833,661
Weighted Average Number of Shares Outstanding, Diluted 4,832,096 4,835,639